The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms

The age-related decrease in skeletal muscle mass together with the loss of muscle power and function is defined sarcopenia. Mounting evidence suggests that the prevalence of sarcopenia is higher in patients with type 2 diabetes mellitus (T2DM), and different mechanisms may be responsible for this as...

Descripción completa

Detalles Bibliográficos
Autores principales: Massimino, Elena, Izzo, Anna, Riccardi, Gabriele, Della Pepa, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393336/
https://www.ncbi.nlm.nih.gov/pubmed/34440727
http://dx.doi.org/10.3390/cells10081958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393336/
https://www.ncbi.nlm.nih.gov/pubmed/34440727
http://dx.doi.org/10.3390/cells10081958

Ejemplares similares